Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Vin Cent ^a   Huang, Kuo How ^a   Peng, Kang Yung ^a   Tsai, Yao Chou ^b   Wu, Che Hsiung ^b   Wang, Shuo Meng ^a   Yang, Shao Yu ^a   Lin, Lian Yu ^a   Chang, Chin Chen ^a   Lin, Yen Hung ^a   Lin, Shuei Liong ^a   Chu, Tzong Shinn ^a   Wu, Kwan Dun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ATP1A1 PROTEIN, HUMAN; ATP2B3 PROTEIN, HUMAN; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN, HUMAN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR PROTEIN;

ADENOMA; ADULT; AGE; AGED; BLOOD; CLINICAL TRIAL; FEMALE; GENETICS; HUMAN; HYPERALDOSTERONISM; MALE; METABOLISM; MIDDLE AGED; MUTATION; PREVALENCE; SECRETION (PROCESS); TAIWAN;

ADENOMA; ADULT; AGE FACTORS; AGED; ALDOSTERONE; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; PREVALENCE; SODIUM-POTASSIUM-EXCHANGING ATPASE; TAIWAN;

EID: 84931292049     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11396     Document Type: Article

References (59)

1. Wu, K. D. et al. Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide. J Formos Med Assoc 100, 598-603 (2001
2. Young, W. F., Jr. Minireview: Primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 144, 2208-2213 (2003
3. Rossi, G. P. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. Journal of the American College of Cardiology 48, 2293-2300 (2006
4. Yang, N. P., Chan, C. L., Yu, I. L., Lee, C. Y. & Chou, P. Estimated prevalence of orthopaedic fractures in Taiwan-A cross-sectional study based on nationwide insurance data. Injury 41, 1266-1272 (2010
5. Petramala, L. et al. Bone and mineral metabolism in patients with primary aldosteronism. International journal of endocrinology 2014, 836529 (2014
6. Choi, M. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (New York, N.Y 331, 768-772 (2011
7. Beuschlein, F. et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nature genetics 45, 440-444 (2013
8. Gomez-Sanchez, C. E., Kuppusamy, M. & Gomez-Sanchez, E. P. Somatic mutations of the ATP1A1 gene and aldosteroneproducing adenomas. Molecular and cellular endocrinology 14, S0303-7207 (2014
9. Scholl, U. I. et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nature genetics 45, 1050-1054 (2013
10. Azizan, E. A. et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature genetics 45, 1055-1060 (2013
11. Angelidis, C. et al. Cystatin C: An emerging biomarker in cardiovascular disease. Current topics in medicinal chemistry 13, 164-179 (2013
12. Al-Salameh, A., Cohen, R. & Desailloud, R. Overview of the genetic determinants of primary aldosteronism. The application of clinical genetics 7, 67-79 (2014
13. Williams, J. S. Evolving research in nongenomic actions of aldosterone. Curr Opin Endocrinol Diabetes Obes 20, 198-203 (2013
14. Monticone, S., Else, T., Mulatero, P., Williams, T. A. & Rainey, W. E. Understanding primary aldosteronism: Impact of next generation sequencing and expression profiling. Molecular and cellular endocrinology 399, 311-320 (2015
15. Scholl, U. I. et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proceedings of the National Academy of Sciences of the United States of America 109, 2533-2538 (2012
16. Wu, V. C. et al. Primary Aldosteronism: Diagnostic Accuracy of the Losartan and Captopril Tests. Am J Hypertens 22, 821-827 (2009
17. Kuo, C. C. et al. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst 12, 348-357 (2011
18. Chao, C. T. et al. Diagnosis and management of primary aldosteronism: An updated review. Annals of medicine 45, 375-383 (2013
19. Wu, C. H. et al. Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism. PloS one 8, e67417 (2013
20. Sechi, L. A. et al. Long-term renal outcomes in patients with primary aldosteronism. Jama 295, 2638-2645 (2006
21. Mulatero, P. et al. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 83, 3996-4001 (1998
22. Wu, V. C. et al. Diagnosis of primary aldosteronism: Comparison of post-captopril active renin concentration and plasma renin activity. Clin Chim Acta 411, 657-663 (2010
23. Wu, V. C. et al. Primary aldosteronism: Changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J Hypertens 29, 1778-1786 (2011
24. Wu, V. C. et al. Endothelial Progenitor Cells in Primary Aldosteronism: A Biomarker of Severity for Aldosterone Vasculopathy and Prognosis. J Clin Endocrinol Metab 96, 3175-3183 (2011
25. Lin, Y. H. et al. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. European journal of clinical investigation 41, 743-750 (2011
26. Devereux, R. B. & Reichek, N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55, 613-618 (1977
27. Chen, S. F. et al. Clinical Outcomes in Patients Undergoing Laparoscopic Adrenalectomy for Unilateral Aldosterone Producing Adenoma: Partial Versus Total Adrenalectomy. Journal of endourology/Endourological Society 28, 1103-1106 (2014
28. Azizan, E. A. et al. Somatic Mutations Affecting the Selectivity Filter of KCNJ5 Are Frequent in 2 Large Unselected Collections of Adrenal Aldosteronomas. Hypertension (2012
29. Fernandes-Rosa, F. L. et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354-361 (2014
30. Wu, V. C. et al. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 54, 665-673 (2009
31. Catena, C. et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 50, 911-918 (2007
32. Cleveland, W. S. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74, 829-836 (1979
33. Woo, M. J., Reiter, J. P. & Karr, A. F. Estimation of propensity scores using generalized additive models. Statistics in medicine 27, 3805-3816 (2008
34. Mulatero, P. et al. Prevalence and characteristics of familial hyperaldosteronism: The PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension 58, 797-803 (2011
35. Rossi, G. P. et al. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. J Hypertens 32, 1514-1522 (2014
36. Boulkroun, S. et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59, 592-598 (2012
37. Taguchi, R. et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab 97, 1311-1319 (2012
38. Calo, L. A. et al. Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity. Journal of endocrinological investigation 33, 48-53 (2010
39. Petramala, L. et al. Oxidative stress in patients affected by primary aldosteronism. J Hypertens 32, 2022-2029 (2014
40. Jeglitsch, G. et al. The cardiac acetylcholine-activated, inwardly rectifying K+-channel subunit GIRK1 gives rise to an inward current induced by free oxygen radicals. Free Radic Biol Med 26, 253-259 (1999
41. Shattock, M. J. & Matsuura, H. Measurement of Na(+ )-K+ pump current in isolated rabbit ventricular myocytes using the whole-cell voltage-clamp technique. Inhibition of the pump by oxidant stress. Circulation research 72, 91-101 (1993
42. Tan, C. M., Xenoyannis, S. & Feldman, R. D. Oxidant stress enhances adenylyl cyclase activation. Circulation research 77, 710-717 (1995
43. Ruppersberg, J. P. et al. Regulation of fast inactivation of cloned mammalian IK(A) channels by cysteine oxidation. Nature 352, 711-714 (1991
44. Duprat, F. et al. Susceptibility of cloned K+ channels to reactive oxygen species. Proc Natl Acad Sci U S A 92, 11796-11800 (1995
45. Arnesen, T. et al. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: A population-based study from Western Norway. Langenbeck's archives of surgery/Deutsche Gesellschaft fur Chirurgie 398, 869-874 (2013
46. Ip, J. C. et al. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism. ANZ journal of surgery 10, [Epub ahead of print] (2013
47. Catena, C. et al. Relationships of plasma renin levels with renal function in patients with primary aldosteronism. Clin J Am Soc Nephrol 2, 722-731 (2007
48. Takahashi, T. et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature medicine 5, 434-438 (1999
49. Rossi, G. P. et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 51, 1366-1371 (2008
50. Wu, V. C. et al. Diagnosis and Management of Primary Aldosteronism. Acta Nephrologica 26, 111-120 (2012
51. Fadini, G. P. et al. Peripheral blood CD34+ KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke; a journal of cerebral circulation 37, 2277-2282 (2006
52. Horita, Y. et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis 37, 884-889 (2001
53. Pierce, G. L. et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension 52, 72-79 (2008
54. Callera, G. E. et al. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 45, 773-779 (2005
55. Monticone, S. et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab 97, E1567-1572 (2012
56. Kitamoto, T. et al. Comparison of Cardiovascular Complications in Patients with and without KCNJ5 Gene Mutations Harboring Aldosterone-producing Adenomas. Journal of atherosclerosis and thrombosis 22, 191-200 (2015
57. Nishikawa, T., Saito, J. & Omura, M. Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocrine journal 54, 487-495 (2007
58. Lu, K. C., Wu, C. C., Yen, J. F. & Liu, W. C. Vascular calcification and renal bone disorders. TheScientificWorldJournal 2014, 637065 (2014
59. Lin, J. H. et al. Eligibility for Statin Therapy According to New Cholesterol Guidelines on Primary Aldosteronism. J Clin Endocrinol Metab [epublish] (2015).